{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:29:09Z","timestamp":1792787349989,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00428-022-03412-6","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T02:02:14Z","timestamp":1665367334000},"page":"265-279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas"],"prefix":"10.1007","volume":"482","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5009-4808","authenticated-orcid":false,"given":"Andrew L.","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Narbaitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"3412_CR1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR et al (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. https:\/\/doi.org\/10.1182\/blood.2022015851","journal-title":"Blood"},{"key":"3412_CR2","unstructured":"Swerdlow S, Campo E, Harris N, et al (eds) (2017) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon"},{"key":"3412_CR3","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","volume":"109","author":"L de Leval","year":"2007","unstructured":"de Leval L, Rickman DS, Thielen C et al (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109:4952\u20134963","journal-title":"Blood"},{"key":"3412_CR4","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","volume":"67","author":"PP Piccaluga","year":"2007","unstructured":"Piccaluga PP, Agostinelli C, Califano A et al (2007) Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 67:10703\u201310710","journal-title":"Cancer Res"},{"key":"3412_CR5","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","volume":"102","author":"MP Dobay","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E et al (2017) Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica 102:e148\u2013e151. https:\/\/doi.org\/10.3324\/haematol.2016.158428","journal-title":"Haematologica"},{"key":"3412_CR6","unstructured":"Swerdlow S, Campo E, Harris N, et al. (eds) (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon"},{"key":"3412_CR7","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1182\/bloodadvances.2021005171","volume":"5","author":"M Rodriguez","year":"2021","unstructured":"Rodriguez M, Alonso-Alonso R, Tomas-Roca L et al (2021) Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers. Blood Adv 5:5588\u20135598. https:\/\/doi.org\/10.1182\/bloodadvances.2021005171","journal-title":"Blood Adv"},{"key":"3412_CR8","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","volume":"128","author":"D Vallois","year":"2016","unstructured":"Vallois D, Dobay MP, Morin RD et al (2016) Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. Blood 128:1490\u20131502. https:\/\/doi.org\/10.1182\/blood-2016-02-698977","journal-title":"Blood"},{"key":"3412_CR9","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","volume":"4","author":"NE Lewis","year":"2020","unstructured":"Lewis NE, Petrova-Drus K, Huet S et al (2020) Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv 4:2261\u20132271. https:\/\/doi.org\/10.1182\/bloodadvances.2020001636","journal-title":"Blood Adv"},{"key":"3412_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jmoldx.2021.04.013","volume":"23","author":"F Drieux","year":"2021","unstructured":"Drieux F, Ruminy P, Sater V et al (2021) Detection of gene fusion transcripts in peripheral T-cell lymphoma using a multiplexed targeted sequencing assay. J Mol Diagn 23:929\u2013940. https:\/\/doi.org\/10.1016\/j.jmoldx.2021.04.013","journal-title":"J Mol Diagn"},{"key":"3412_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","volume":"32","author":"J Steinhilber","year":"2019","unstructured":"Steinhilber J, Mederake M, Bonzheim I et al (2019) The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations. Mod Pathol 32:1123\u20131134. https:\/\/doi.org\/10.1038\/s41379-019-0254-4","journal-title":"Mod Pathol"},{"key":"3412_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.leu.2404045","volume":"20","author":"B Streubel","year":"2006","unstructured":"Streubel B, Vinatzer U, Willheim M et al (2006) Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 20:313\u2013318","journal-title":"Leukemia"},{"key":"3412_CR13","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1182\/blood.2020009004","volume":"137","author":"L Falchi","year":"2021","unstructured":"Falchi L, Ma H, Klein S et al (2021) Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study. Blood 137:2161\u20132170. https:\/\/doi.org\/10.1182\/blood.2020009004","journal-title":"Blood"},{"key":"3412_CR14","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1182\/blood-2018-04-840538","volume":"132","author":"F Lemonnier","year":"2018","unstructured":"Lemonnier F, Dupuis J, Sujobert P et al (2018) Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma. Blood 132:2305\u20132309. https:\/\/doi.org\/10.1182\/blood-2018-04-840538","journal-title":"Blood"},{"key":"3412_CR15","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1182\/bloodadvances.2020002396","volume":"4","author":"P Ghione","year":"2020","unstructured":"Ghione P, Faruque P, Mehta-Shah N et al (2020) T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed\/refractory peripheral T-cell lymphoma. Blood Adv 4:4640\u20134647. https:\/\/doi.org\/10.1182\/bloodadvances.2020002396","journal-title":"Blood Adv"},{"key":"3412_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","volume":"43","author":"BM Basha","year":"2019","unstructured":"Basha BM, Bryant SC, Rech KL et al (2019) Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with t-follicular helper phenotype. Am J Surg Pathol 43:1282\u20131290. https:\/\/doi.org\/10.1097\/PAS.0000000000001315","journal-title":"Am J Surg Pathol"},{"key":"3412_CR17","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.1182\/bloodadvances.2021005249","volume":"5","author":"C Syrykh","year":"2021","unstructured":"Syrykh C, Gorez P, Pericart S et al (2021) Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS. Blood Adv 5:4590\u20134593. https:\/\/doi.org\/10.1182\/bloodadvances.2021005249","journal-title":"Blood Adv"},{"key":"3412_CR18","doi-asserted-by":"publisher","unstructured":"Amador C, Bouska A, Wright G, et al (2022) Gene expression signatures for the accurate diagnosis of peripheral T-cell lymphoma entities in the routine clinical practice J Clin Oncol:JCO2102707. https:\/\/doi.org\/10.1200\/JCO.21.02707","DOI":"10.1200\/JCO.21.02707"},{"key":"3412_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/modpathol.2016.113","volume":"29","author":"M Alikhan","year":"2016","unstructured":"Alikhan M, Song JY, Sohani AR et al (2016) Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-\/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic. Mod Pathol 29:1173\u20131182. https:\/\/doi.org\/10.1038\/modpathol.2016.113","journal-title":"Mod Pathol"},{"key":"3412_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","volume":"156","author":"Y Xie","year":"2021","unstructured":"Xie Y, Jaffe ES (2021) How I diagnose angioimmunoblastic T-cell lymphoma. Am J Clin Pathol 156:1\u201314. https:\/\/doi.org\/10.1093\/ajcp\/aqab090","journal-title":"Am J Clin Pathol"},{"key":"3412_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/ajcp\/aqaa249","volume":"156","author":"I Abukhiran","year":"2021","unstructured":"Abukhiran I, Syrbu SI, Holman CJ (2021) Markers of follicular helper T cells are occasionally expressed in T-cell or histiocyte-rich large B-cell lymphoma, classic Hodgkin lymphoma, and atypical paracortical hyperplasia a diagnostic pitfall for T-cell lymphomas of T follicular helper origin. Am J Clin Pathol 156:409\u2013426. https:\/\/doi.org\/10.1093\/ajcp\/aqaa249","journal-title":"Am J Clin Pathol"},{"key":"3412_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/PAS.0000000000001414","volume":"44","author":"C Egan","year":"2020","unstructured":"Egan C, Laurent C, Alejo JC et al (2020) Expansion of PD1-positive T cells in nodal marginal zone lymphoma: a potential diagnostic pitfall. Am J Surg Pathol 44:657\u2013664. https:\/\/doi.org\/10.1097\/PAS.0000000000001414","journal-title":"Am J Surg Pathol"},{"key":"3412_CR23","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","volume":"91","author":"D Benharroch","year":"1998","unstructured":"Benharroch D, Meguerian-Bedoyan Z, Lamant L et al (1998) ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 91:2076\u20132084","journal-title":"Blood"},{"key":"3412_CR24","doi-asserted-by":"publisher","unstructured":"Larose H, Prokoph N, Matthews JD, et al. (2020) Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target Haematologica. https:\/\/doi.org\/10.3324\/haematol.2019.238766","DOI":"10.3324\/haematol.2019.238766"},{"key":"3412_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","volume":"27","author":"R Crescenzo","year":"2015","unstructured":"Crescenzo R, Abate F, Lasorsa E et al (2015) Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 27:516\u2013532. https:\/\/doi.org\/10.1016\/j.ccell.2015.03.006","journal-title":"Cancer Cell"},{"key":"3412_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/leu.2017.309","volume":"32","author":"G Hu","year":"2018","unstructured":"Hu G, Dasari S, Asmann YW et al (2018) Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma. Leukemia 32:565\u2013569. https:\/\/doi.org\/10.1038\/leu.2017.309","journal-title":"Leukemia"},{"key":"3412_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","volume":"45","author":"MJ Fitzpatrick","year":"2021","unstructured":"Fitzpatrick MJ, Massoth LR, Marcus C et al (2021) JAK2 Rearrangements are a recurrent alteration in CD30+ systemic T-cell lymphomas with anaplastic morphology. Am J Surg Pathol 45:895\u2013904. https:\/\/doi.org\/10.1097\/PAS.0000000000001708","journal-title":"Am J Surg Pathol"},{"key":"3412_CR28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11930","author":"P Melard","year":"2016","unstructured":"Melard P, Idrissi Y, Andrique L et al (2016) Molecular alterations and tumor suppressive function of the DUSP22 (dual specificity phosphatase 22) gene in peripheral T-cell lymphoma subtypes. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.11930","journal-title":"Oncotarget"},{"key":"3412_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","volume":"117","author":"AL Feldman","year":"2011","unstructured":"Feldman AL, Dogan A, Smith DI et al (2011) Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively-parallel genomic sequencing. Blood 117:915\u2013919","journal-title":"Blood"},{"key":"3412_CR30","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1038\/ncomms4618","volume":"5","author":"JP Li","year":"2014","unstructured":"Li JP, Yang CY, Chuang HC et al (2014) The phosphatase JKAP\/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck. Nat Commun 5:3618. https:\/\/doi.org\/10.1038\/ncomms4618","journal-title":"Nat Commun"},{"key":"3412_CR31","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","volume":"132","author":"RA Luchtel","year":"2018","unstructured":"Luchtel RA, Dasari S, Oishi N et al (2018) Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Blood 132:1386\u20131398. https:\/\/doi.org\/10.1182\/blood-2018-03-838524","journal-title":"Blood"},{"key":"3412_CR32","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1182\/blood.2019000626","volume":"133","author":"RA Luchtel","year":"2019","unstructured":"Luchtel RA, Zimmermann MT, Hu G et al (2019) Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma. Blood 133:2776\u20132789. https:\/\/doi.org\/10.1182\/blood.2019000626","journal-title":"Blood"},{"key":"3412_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","volume":"40","author":"RL King","year":"2016","unstructured":"King RL, Dao LN, McPhail ED et al (2016) Morphologic features of ALK-negative anaplastic large cell lymphomas with DUSP22 rearrangements. Am J Surg Pathol 40:36\u201343. https:\/\/doi.org\/10.1097\/PAS.0000000000000500","journal-title":"Am J Surg Pathol"},{"key":"3412_CR34","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar ER, Jaffe ES, Said JW et al (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124:1473\u20131480. https:\/\/doi.org\/10.1182\/blood-2014-04-571091","journal-title":"Blood"},{"key":"3412_CR35","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1111\/bjh.15860","volume":"186","author":"G Hapgood","year":"2019","unstructured":"Hapgood G, Ben-Neriah S, Mottok A et al (2019) Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma. Br J Haematol 186:e28\u2013e31. https:\/\/doi.org\/10.1111\/bjh.15860","journal-title":"Br J Haematol"},{"key":"3412_CR36","first-page":"359A","volume":"92","author":"E Parrilla Castellar","year":"2012","unstructured":"Parrilla Castellar E, Grogg K, Law M et al (2012) Rearrangements at the 6p253 locus identify a subset of systemic ALK-negative anaplastic large cell lymphomas with favorable prognosis. Lab Invest 92:359A (abstract)","journal-title":"Lab Invest"},{"key":"3412_CR37","doi-asserted-by":"publisher","unstructured":"Boi M, Rinaldi A, Kwee I, et al. (2013) PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma Blood 122:2683\u20132693. https:\/\/doi.org\/10.1182\/blood-2013-04-497933","DOI":"10.1182\/blood-2013-04-497933"},{"key":"3412_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","volume":"127","author":"I Scarfo","year":"2016","unstructured":"Scarfo I, Pellegrino E, Mereu E et al (2016) Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood 127:221\u2013232. https:\/\/doi.org\/10.1182\/blood-2014-12-614503","journal-title":"Blood"},{"key":"3412_CR39","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","volume":"104","author":"I Bonzheim","year":"2004","unstructured":"Bonzheim I, Geissinger E, Roth S et al (2004) Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 104:3358\u20133360","journal-title":"Blood"},{"key":"3412_CR40","doi-asserted-by":"publisher","first-page":"10087","DOI":"10.1038\/ncomms10087","volume":"7","author":"TI Malcolm","year":"2016","unstructured":"Malcolm TI, Villarese P, Fairbairn CJ et al (2016) Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress. Nat Commun 7:10087. https:\/\/doi.org\/10.1038\/ncomms10087","journal-title":"Nat Commun"},{"key":"3412_CR41","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","volume":"120","author":"G Vasmatzis","year":"2012","unstructured":"Vasmatzis G, Johnson SH, Knudson RA et al (2012) Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 120:2280\u20132289. https:\/\/doi.org\/10.1182\/blood-2012-03-419937","journal-title":"Blood"},{"key":"3412_CR42","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal J, Wright G, Wang C et al (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood 123:2915\u20132923. https:\/\/doi.org\/10.1182\/blood-2013-11-536359","journal-title":"Blood"},{"key":"3412_CR43","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood.2019000779","volume":"134","author":"C Amador","year":"2019","unstructured":"Amador C, Greiner TC, Heavican TB et al (2019) Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry. Blood 134:2159\u20132170. https:\/\/doi.org\/10.1182\/blood.2019000779","journal-title":"Blood"},{"key":"3412_CR44","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican TB, Bouska A, Yu J et al (2019) Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood 133:1664\u20131676. https:\/\/doi.org\/10.1182\/blood-2018-09-872549","journal-title":"Blood"},{"key":"3412_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41379-019-0279-8","volume":"33","author":"MA Laginestra","year":"2020","unstructured":"Laginestra MA, Cascione L, Motta G et al (2020) Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. Mod Pathol 33:179\u2013187. https:\/\/doi.org\/10.1038\/s41379-019-0279-8","journal-title":"Mod Pathol"},{"key":"3412_CR46","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015854","author":"L de Leval","year":"2022","unstructured":"de Leval L, Alizadeh AA, Bergsagel PL et al (2022) Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. https:\/\/doi.org\/10.1182\/blood.2022015854","journal-title":"Blood"},{"key":"3412_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01022-w","author":"A Nicolae","year":"2022","unstructured":"Nicolae A, Bouilly J, Lara D et al (2022) Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-022-01022-w","journal-title":"Mod Pathol"},{"key":"3412_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3324\/haematol.2017.180430","volume":"103","author":"SB Ng","year":"2018","unstructured":"Ng SB, Chung TH, Kato S et al (2018) Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes. Haematologica 103:278\u2013287. https:\/\/doi.org\/10.3324\/haematol.2017.180430","journal-title":"Haematologica"},{"key":"3412_CR49","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280003","author":"CMM Wai","year":"2022","unstructured":"Wai CMM, Chen S, Phyu T et al (2022) Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2021.280003","journal-title":"Haematologica"},{"key":"3412_CR50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","volume":"39","author":"S Kato","year":"2015","unstructured":"Kato S, Asano N, Miyata-Takata T et al (2015) T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases. Am J Surg Pathol 39:462\u2013471. https:\/\/doi.org\/10.1097\/PAS.0000000000000323","journal-title":"Am J Surg Pathol"},{"key":"3412_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3960\/jslrt.20001","volume":"60","author":"S Kato","year":"2017","unstructured":"Kato S, Yamashita D (2017) Nakamura S (2020) Nodal EBV+ cytotoxic T-cell lymphoma: a literature review based on the WHO classification. J Clin Exp Hematop 60:30\u201336. https:\/\/doi.org\/10.3960\/jslrt.20001","journal-title":"J Clin Exp Hematop"},{"key":"3412_CR52","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3324\/haematol.2019.226647","volume":"105","author":"F Drieux","year":"2020","unstructured":"Drieux F, Ruminy P, Abdel-Sater A et al (2020) Defining signatures of peripheral T-cell lymphoma with a targeted 20-marker gene expression profiling assay. Haematologica 105:1582\u20131592. https:\/\/doi.org\/10.3324\/haematol.2019.226647","journal-title":"Haematologica"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03412-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T19:17:58Z","timestamp":1674847078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03412-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3412"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03412-6","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}